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Until recently, the initial changes in osteoarthritis
have been considered to be essentially a mechanical degenerative
process and beyond efforts at prevention or control.

The se¬

quence of gross and microscopic changes in articular cartilage
which occurs in this condition is well known.

The hyaline car¬

tilage, normally a pearly grey, smooth and glistening substance,
becomes opaque, dull and pitted with yellow discoloration.

The

small grooves and pits which have formed in these areas enlarge
producing deep clefts and the tissue loses its resilience, upon
which the nutrition of chondrocytes is dependent.

There is a

general paucity of cellular elements with occasional clusters
of proliferating chondrocytes.

Histologically the articular sur¬

face shows fibrillation with loss of mucopolysaccharide as evi¬
denced by an absence of metachromatic staining of these areas
with toluidine blue.

This process leads inevitably to erosion

of the cartilage exposing the pain sensitive subchondral bene.
At the margins of the articular surface spur formation takes place.
These are initially cartilaginous, but become osseous by
chondral ossification.

en-

Cartilaginous loose bodies or "joint mice"

are often found in the joint space.

(1)

The biochemical alterations which parallel these changes
are increasingly the subject of numerous investigations.

In 1944,

Hirsch, investigating the pathogenesis of chondromalacia of the
patella, found that the chondroitin sulfate

(CSA) content of the

involved cartilage was often decreased in samples which grossly
showed no fissures,

Kellgren, in a review of the problem,

proposed that a decrease in the polysaccharide content of carti-

(2)

lage resulted in a breaking up and disintegration of unsuoported
(3)
collagen fibrils by wear and tear.

B. F. Matthews, investi¬

gating the collagen/CSA ratio in fibrillar cartilage from osteoarthritic joints, found that the ratio was greater in fibriUated
than in normal cartilage reflecting a loss of CSA of greater mag-

(4)
nitude than loss of collagen.
The enzymatic degradation of chondromucoprotein (CMP)
with splitting off of CSA may be involved in the biochemical
changes noted.

Trypsin and testicular hyaluronidase have been

shown to decrease the viscosity of CMP solutions, but lysozyme
(5)
has no effect.
Intravenous papain causes the degradation of
CMP in vivo, resulting in loss of basophilic and metachromatic

(6)
staining of hyaline cartilage.

Tsaltas has reported a de¬

pletion of CMP and CSA from rabbit cartilage after the adminis¬
tration of intravenous papain.
(7)
greater than the CMP loss.

The loss of CSA was found to be
Incubation of cartilage strips

with bovine plasmin results in a liberation of considerable CSA
into the incubation medium as compared to control samples and in-

(8)
cubation media to which antiplasminogen had been added.

Bac(9)

terial enzymes which degrade CMP have also been reported.
Recently Ziff et a1. have reported the enzymatic degradation of the
CSA-protein complex by leukocytic and synovial extracts.

Activity

of the synovial extracts was clearly related to tissue content of
polymorphonuclear leukocytes in these rheumatoid joints.

(10) The

decrease in ester sulfate content of articular cartilage strips
incubated in Tyrode1s solution as a control was found to be greater
than that produced by human plasmin during incubations of 15 hours

(3)

duration reported by Chrisman et al.

(11)

The latter findings raised the question of the pre¬
sence of an enzyme in human articular cartilage itself which
could cause the degradation of the protein-CSA complex.

It is

the purpose of this paper to investigate the possible presence
of such an enzyme in human articular cartilage by incubating CMP
with cell free extracts of normal and pathological cartilage and
measuring the reaction by viscometry.

Methods
Chondromucoprotein (CMP) was prepared from calf nasal
cartilage according to the method of Shatton and Schubert.

^ ^

Solutions of varying concentration were prepared with saline phosphate buffer, pH 7.0.
Cell free extracts of surgical specimens were prepared
in the following manner.

The cartilage samples were weighed and

thoroughly homogenized in 0.9N NaCl (1 gram to 45 ml.) in a Virtis-45 machine at 4°C.
4000 RPM for 45 minutes.

These homogenates were centrifuged at
The cell free supernatants were re¬

tained for the incubations.
The degradation of chondromucoprotein by these ex¬
tracts was studied by viscometry.

Six ml. of 1% chondromucopro¬

tein and two ml. of each extract were incubated in Cannon-Fiske
#100 viscometers at 37°C for three hours.

Efflux time deter¬

minations were made at 0,5,10,15 and 30 minutes and at succeed¬
ing 30 minute intervals to three hours.

Per cent initial rela¬

tive viscosity was calculated by the formula; 7.initial relative
viscosity = to-tx where tQ is the efflux time at the initial readtx

(4)

ing and tx is the efflux time at any succeeding determination.
The enzymatic nature of the reaction was investigated
in several ways.

Trace amounts of various enzyme inhibitors in¬

cluding HgCl2> NaCN and IAA were added to the reaction mixture.
The extracts were heated to 60°C for 10 minutes before incuba¬
tion with chondromucoprotein.

Finally the concentration of CMP

was varied from 0.75 to 1.5% and its effect on reaction rate re¬
corded .
A study of the reaction products was also carried out.
After the reaction was terminated by freezing, the reaction mixture
was filtered through an ultra fine fritted glass bacterial filter
(!,Pyrex'! Brand Chemical Glass, #33990, UF porosity) to remove
protein.

(12)

The filtrate was spotted (0.04ml.) on #1 Whatman

paper and electrophoresis carried out with chondroitin sulfate
A and C, prepared from calf nasal septum and steer tendon respec¬
tively by the method of Einbinder and Schubert, as control spots. ^
The filtered reaction mixture was also analyzed for the presence of
amino acids and sugars by paper chromatography with a filtrate of
17. CMP solution incubated alone for three hours with buffer ser¬
ving as a control.

Chromatographic technique for sugars involved

spotting of 50 microliters on Whatman #4 paper and a solvent pre¬
pared as follows:

600ml, n-butanol, 165ml. ethanol, 400ml. dis¬

tilled water and 10ml. NHg (3.2ml. cone. NH^ (w/v) made up to 100
ml. with water).

Chromatography was run for 40 hours and sugars

were stained by a process involving the use of aniline - phthalate
spray and heating to 100 - 105 C for 10 minutes.

Identification

of amino acids involved a two phase process in which 50 micro-

.

)

.

)

(5)

liters were spotted on Whatman #4 paper.

Water saturated phenol

with 6-8 drops of concentrated ammonia and a trace of NaCN was
used as solvent in the first phase.

Second phase solvent was pre¬

pared from 600 ml. collidine, 600 ml. 2,4 - lutidine and 1000 ml.
distilled water with 6-8 drops of diethylamine added.

Paper was

stained with 0.157. ninhydrin in acetone.

Results
I

Effect of Extracts on Chondromucoprotein Viscosity
CMP in 17. solution was incubated with neutral saline-

phosphate buffer for three hours as a control.

There was no de¬

crease in the viscosity of the solution.
Six normal cartilage extracts showed an average vis¬
cosity reducing activity of 6.4% with a range of 1.9 to 10.9%
(table 1).

Table 1
Viscosity Reducing Activity of Normal Cartilage Extracts
sample #

age

% decrease in relative viscosity
(3 hours)

1

17

9.3

3

18

2.4

7

9

7.7

8

7

1.9

17

17

10.9

22

30

6.2

Eight pathological samples were obtained from osteoarthritic joints.

Of these, five were from fibrillated areas and

(6)
three were spur cartilage.

The five chondromalacic samples showed

an average viscosity reducing activity of 9.9% with a range of 2.6%
to 19.1%.

The spur cartilage on the other hand showed an average

viscosity reducing activity of 3.1% with a range of 2.7% to 3.6%.
(table 2)

Although the chondromalacic samples showed an activity

which was significantly greater than that of spur cartilage, they
did not show much greater activity than the normal samples.

Table 2
Viscosity Reducing Activity of Hypertrophic Arthritic Cartilage
Extracts
ample #

source

2

C

6

age

% decrease in relative viscosity
(3 hours)

35

19.1

C

20

2.6

14

c

30

13.0

15

c

50

9.6

20

c

19

5.4

4

s *

62

2.7

5

s

27

3.3

18

s

46

3.6

*

* C = Chondromalacia;

* S * Spur cartilage

Several other tissues were studied including loose bodies
and one chondrosarcoma.

Extracts of three loose bodies showed an

average viscosity reducing activity of 3.1.

The chondrosarcoma ex¬

tract had a 17.1% viscosity reducing activity in three hours (table 3).

(7)

Table 3

Viscos ity Reducing Activity of Other Pathological Extracts
Sample

Source

7t decrease in relative viscosity
(3 hours)

9

Loose Bodies

3.8

24

Loose Bodies

2.8

36

Loose Bodies

2.7

11

Chondrosarcoma

17.1

(8)
II

Enzyme Characteristics.
The most active osteoarthritic extract was used in a

series of experiments to demonstrate the enzymatic nature of the
reaction.

Enzyme inhibitors in trace amounts were added to the

reaction mixture,
tract by about 507o.

NaCN and HgCl2 reduced the activity of the ex¬
IAA, however, had no effect.

Heating of the

extract prior to incubation with CMP destroyed its activity al¬
most completely (figure 1).

Figure 1

Effect of Heat, HgClp and NaCN on viscosity reducing
activity of cell free human cartilage extracts.

(9)
The effect of changes in enzyme concentration, pH and
temperature have not been studied.

However, the effect of change

in substrate concentration was studied by varying the concentra¬
tion of chondromucoprotein from 0,75 to 1,25% while holding enzyme
concentration constant.

As is illustrated in figure 2 an increase

in chondromucoprotein concentration resulted in a corresponding in¬
crease in reaction rate, a pattern typical of any chemical reaction.

Figure 2

Effect of changes in CMP concentration on rate of
viscosity reduction by cell free human cartilage
extracts.

(10)
The reaction rate using 1.5% chondroraucoprotein was identical to
that of the 1.25% reaction suggesting that the reaction had reached
a maximum velocity which could not be changed by further increase
in substrate concentration.

This phenomenon is characteristic of

those chemical reactions which are enzymatic in nature and is due
to the limited rate of formation of the enzyme - substrate complex.
Further study of this problem was curtailed by our inability to
prepare a suitable solution of chondroraucoprotein with a concentra¬
tion greater than 1.5%.

We feel that the evidence is sufficient to

indicate that the decrease in relative viscosity of chondromucoprotein solutions which we have observed is due to enzyme activity.

Ill

Analysis of Reaction Products
The problem of site of action of the enzyme or emzymes

involved in the process of chondromucoprotein degradation was
approached by an analysis of reaction products.
main possibilities:

1)

There were three

the enzyme was proteolytic in nature, de¬

grading the protein to amino acids and peptides,

2)

it was a

chondroitinase degrading the CSA portion of the complex; or, 3) it
was an enzyme splitting off chondroitin sulfate intact from the
protein.
After ultrafiltration of the reaction mixture to remove
residual protein, the filtrate was electrophoresed with chondroitin
sulfate A and C as control spots and also subjected to paper chomatographic analysis.

Electrophoresis of the filtrate revealed a

large metachromatic spot with a mobility identical to that of
chondroitin sulfate C, but slightly less than that of chondroitin
sulfate A, figure 3 and 4.

(11)
Figure 3

Ch-S04 c

UNKNOWN

Electrophoresis of protein free filtrate of reaction mixture
and chondroitin sulfate C. Acetate buffer, pH 4.3.

Figure 4

Electrophoresis of protein free filtrate of reaction mixture
and chondroitin sulfate A. Acetate buffer, pH 4,3.

'

)

(12)

As the size and metachromaticity of the spot were notable,
it was felt that undegraded CSA was a major reaction product.

Chroma¬

tography was carried out to investigate the possibility that there
might be some mucopolysaccharide degradation or proteolytic activity
present in the cartilage extracts.

Neither amino acids, peptides

or sugars were demonstrable in the filtrate by this method.

It is

felt that CSA Is being split from the protein at or very near the
protein-chondroitin sulfate bond releasing CSA intact or perhaps
with a small polypeptide attached.

Discussion
Although the intermediate steps in the synthesis of the
CSA molecule through the UDPG system and nactive" sulfate have been
well demonstrated,

(14, 15, 16,) the sequence of steps by which the

ground substance of mammalian cartilage is degraded is poorly under¬
stood,

In approaching this problem it is necessary to determine

the initial biochemical changes which occur in normal and patholo¬
gical states.

There is neither histological nor biochemical evid¬

ence that degradation of collagen is involved in the early steps of
this process.

There has been no demonstration of a collagenase

which is functional at neutral pH in mammalian tissues.

The work

of Matthews has demonstrated a loss of CSA rather than collagen in
fibrillated cartilage from osteoarthritic joints.

The problem then

clearly involves the catabolism of the other major component of the
ground substance, chondromucoprotein.
There are a variety of known enzymes which are capable of
degrading CMP, but which can not logically be indicted as the agent
involved in the degeneration of the ground substance in osteoarthri-

(13)
tis.

The various plant and bacterial enzymes, of which papain is

the most noteworthy, simply are not present in the sterile joints.
There are insufficient polymorphonuclear leukocytes involved in
the osteoarthritic process to incriminate the leukocytic enzyme
which Ziff has proposed as a factor in the destruction of arti¬
cular cartilage in rheumatoid arthritis.

The proposal has been

made that plasmin, a proteolytic agent involved in fibrinolysis,
may be involved in CMP catabolism in the arthritic joint.

Cer¬

tainly this enzyme could gain access to the joint surface as a
result of trauma and hemorrhage into the synovial space.

It has

been recently shown that plasmin can indeed degrade CMP in an
isolated system of enzyme and CMP solution.

np\
' Lack's investi¬

gation of the problem by incubation of cartilage strips with plas¬
min demonstrated a considerable liberation of CSA as compared to
control incubations or those to which antiplasminogen had been added
However, repeated attempts to demonstrate degenerative changes in
vivo by multiple injections of plasmin into intact and traumatized
animal joints have been singularly unproductive.

(11) This paper,

v

however, presents evidence for the presence of an enzyme in nor¬
mal and osteoarthritic cartilage which may be the agent causing
the initial steps in CMP catabolism.
Having demonstrated such an enzyme in both normal and
pathological cartilage, the next question which demands a solution
is that of the site of action of this enzyme.

There are theoreti¬

cally four potential sites for enzymatic cleavage of this com¬
pound whose structure presumably is a linear arrangement of CSA
complexes bound to protein.

(17)
s
These include 1) proteolysis of

(8)

r

\

(14)
Schubert's protein, 2) depolymerization or further degradation of
the polysaccharide, 3) chondrosulfatase activity and 4) cleavage
of the protein to polysaccharide bond.
Analysis of osteoarthritic joint fluids reveals fully
polymerized CMP staining metachromatically and particulate cartilage
containing collagen.

Two studies involving an analysis of joint

fluids have shown no significant difference in the glucosamine/
galactosamine ratio in normal and pathological joint fluids with
the exception of one patient in each series who showed an elevated
galactosamine.

Repeated attempts to demonstrate chondro¬

sulfatase activity in cell-free extracts of mammalian connective
and parenchymal tissues (costal cartilage, cornea, subcutaneous
tissue, liver, kidney and spleen) by in vitro incubation with S
labeled chondroitin sulfate have been singularly unproductive.^'^
Studies of the fate of the SO4 portion subcutaneously injected
chondroitin sulfate labeled with S

^

'

and

6F

utilizing cartilage strip incubation techniques

3

metabolism
have, how¬

ever, been suggestive of the presence of such an enzyme.

Recent

work by Thomas et al, comparing the effects of large doses of
vitamin A and of papain has shown a similarity of observable altera¬
tion in the cartilage matrix - loss of metachromaticity with an
increase of a substance in serum presumed to be chondroitin sul¬
fate because of its turbidimetric characteristics after treatment
with hexaminecobaltic chloride and a loss of S

from articular

and epiphyseal cartilage.^2) The suggestion was made that vitamin
A produced these changes by activation of a proteolytic enzyme in
cartilage which had an action similar to papain.

The enzyme which

has been demonstrated by our work could be responsible for the
change produced by large doses of vitamin A.

Indeed an intra-

(15)
cellular protease with an optimum pH of 3 has been demonstrated
in normal chondrocytes which produces changes in the matrix closely
resembling those produced by excess vitamin A.
There have been several interesting studies which have
investigated the dynamic biochemical changes in osteoarthritic
cartilage,

Collins and McElligott have shown an increasing avidity

for SO^ in cartilage strips with increasing grade of severity of
osteoarthritic changes in the strips and have noted an increase in
mucopolysaccharide content of the matrix surrounding all clumps in
fibrillated cartilage.

McElligott and Potter have reported a

50% greater uptake of S J by papain treated rabbits as compared to
controls.These changes, which are interpreted as an attempt at
regeneration in injured tissues, are not surprising in view of the
demonstration by Crelin and Southwick of mitosis in adult cartilage
in response to a pathological stimulus.

^6)

McElligot and Potter

suggested that the overall loss of chondroitin sulfate from the
osteoarthritic cartilage is due to the "poor binding power" of the
matrix.

The enzyme which we have demonstrated in human cartilage

may well be responsible for the initial steps in the catabolism
of matrix mucopolysaccharide.

Although we have not demonstrated

a markedly higher activity in osteoarthritic samples as compared
to normal controls, the highest activities recorded were in these
samples.

Fibrillated cartilage showed a much greater activity than

either spur or loose body cartilage.

The chondrosarcoma was the

most active of all samples perhaps reflecting a markedly greater
metabolic turnover.

We can only infer that this enzyme is re¬

sponsible for the degenerative changes noted.

(16)
Recent work has raised the possibility that this pro¬
cess may be reversible.

Chrisman and Southwick in a study of the

effects of adjuvants on SO4 metabolism have noted that incubation
of cartilage strips in a medium containing hydluronic acid or
chondroitin sulfate increased S
sulfate content of the tissue.

35

O4 incorporation and total ester

Incubation with other adjuvants

produced a catabolic effect with decrease in total ester sulfate
in spite of S

35

(271
pickup,'
J

Recent experiments in this labora¬

tory investigating the effects of salicylate and hydrocortisone
on the clearance of CS

35

A from rabbit knee joints have shown a

diminished rate of clearance of

labeled material from treated

as compared to control animals.

Perhaps these agents pro¬

duce a partial reversal or retardation of the degradation of chondr omucoprotein by increasing the concentration of reaction pro¬
ducts in the joint fluid.

Conclusion
An enzyme has been demonstrated in human cartilage which
is capable of degrading chondromucoprotein by splitting off chon¬
droitin sulfate intact.

The levels of activity of this enzyme in

normal, osteoarthritic, loose body, and chondrosarcomatous carti¬
lage have been investigated.

The dynamic biochemical changes in

osteoarthritic cartilage are discussed with reference to the
possible role of this enzyme in hypertrophic arthritis.
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